ADC Therapeutics SA

ADCT · NYSE · SIC 2834: Pharmaceutical Preparations
177
SEC Filings

Business Summary

EX-4.1 3 adct-ex41descriptionofsecu.htm EX-4.1 Document EXHIBIT 4.1 DESCRIPTION OF SHARE CAPITAL AND ARTICLES OF ASSOCIATION The Company We are a Swiss stock corporation ( socit anonyme ) organized under the laws of Switzerland. We were incorporated as a Swiss limited liability company (socit responsabilit limite) on June 6, 2011 with our registered office and domicile in Epalinges, Canton of Vaud, Switzerland. We converted to a Swiss stock corporation under the laws of Switzerland on October 13...

Next Earnings

Q2 FY2026 — expected 2026-09-15

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionADCTdiscussed_in_filing Blockchain & Crypto
topic_mentionADCTdiscussed_in_filing Regulation
topic_mentionADCTdiscussed_in_filing Enterprise
topic_mentionADCTdiscussed_in_filing Sovereign & Government
topic_mentionADCTdiscussed_in_filing Blockchain & Crypto
topic_mentionADCTdiscussed_in_filing Regulation
topic_mentionADCTdiscussed_in_filing Enterprise
topic_mentionADCTdiscussed_in_filing Sovereign & Government
topic_mentionADCTdiscussed_in_filing Blockchain & Crypto
topic_mentionADCTdiscussed_in_filing Regulation
topic_mentionADCTdiscussed_in_filing Enterprise
topic_mentionADCTdiscussed_in_filing Sovereign & Government
topic_mentionADCTdiscussed_in_filing Blockchain & Crypto
topic_mentionADCTdiscussed_in_filing Regulation
topic_mentionADCTdiscussed_in_filing Enterprise
topic_mentionADCTdiscussed_in_filing Sovereign & Government

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-102025-12-310001628280-26-016491EDGAR91K words
2025-03-272024-12-310001628280-25-015131EDGAR—
2024-03-132023-12-310001628280-24-010843EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-102025-09-300001628280-25-051095EDGAR24K words
2025-08-122025-06-300001771910-25-000008EDGAR—
2025-05-142025-03-310001628280-25-025481EDGAR—
2024-11-072024-09-300001628280-24-046050EDGAR—
2024-08-062024-06-300001628280-24-034999EDGAR—
2024-05-062024-03-310001628280-24-020450EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-100001628280-26-016238EDGAR5K words
2026-02-230000950103-26-002466EDGAR—
2026-01-120000950103-26-000349EDGAR—
2026-01-080001628280-26-001386EDGAR—
2025-12-050000950103-25-015818EDGAR—
2025-11-100001628280-25-050796EDGAR—
2025-10-140000950103-25-013103EDGAR—
2025-09-300000950103-25-012514EDGAR—
2025-08-120001771910-25-000006EDGAR—
2025-06-120000950103-25-007282EDGAR—

177 total filings indexed. 158 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADIL — ADIAL PHARMACEUTICALS, INC. AEON — AEON Biopharma, Inc.

Company Identity

CIK0001771910
TickerADCT
ExchangeNYSE
SIC2834: Pharmaceutical Preparations
IncorporatedV8

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 234286a80e24dfef3ee6a9dcfbcc5993b113bd51bae98e6128665ff28bcec6de
parent: 545162e4bd67b0d6da35dcc187f1d28349b75d8ed5f7d6d67370617e604caa6f
content hash: 33ae6e03ba5003de8feec46a81b29d1f091bcb56297a2bfe392cfd73bea5efc9
signed: 2026-04-13T04:43:27.848Z
sources: 9 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf